Minnesota Oncology Hematology, PA ( Site 8001) — Minneapolis, Minnesota

Minnesota Oncology Hematology, PA ( Site 8001) is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, PA ( Site 8001) has participated in 2 clinical trials.

Therapeutic areas: Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Cancer (SCLC).

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, PA ( Site 8001)?

Minnesota Oncology Hematology, PA ( Site 8001) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, PA ( Site 8001) conducted?

Minnesota Oncology Hematology, PA ( Site 8001) has 2 clinical trials on record. Their work covers Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Cancer (SCLC).

Is Minnesota Oncology Hematology, PA ( Site 8001) accredited by Crixeo Health?

Minnesota Oncology Hematology, PA ( Site 8001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology, PA ( Site 8001)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.